Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-20-001186

Options or other derivatives

  • Director acquired 50,562 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tarriff Scott Director 2019-12-31 Grant or award · Stock Option (right to buy) +50,562 50,562 D
Loading xslF345X03/doc4.xml…